Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2.

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2.

Moore NM, Li H, Schejbal D, Lindsley J, Hayden MK. Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2. J Clin Microbiol. 2020 07 23; 58(8).

View in: PubMed

subject areas

Adult
Aged
Clinical Laboratory Techniques
Coronavirus Infections
Female
Humans
Male
Middle Aged
Nasopharynx
Nucleic Acid Amplification Techniques
Pandemics
Pneumonia, Viral
Sensitivity and Specificity
Specimen Handling
Time Factors
United States

authors with profiles

Nicholas Moore
Mary Hayden